⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVBP News
ArriVent BioPharma, Inc. Common Stock
ArriVent BioPharma, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of ArriVent BioPharma, Inc. (AVBP)
accessnewswire.com
AVBP
Form 8-K
sec.gov
AVBP
ArriVent Announces Program Update from the Phase 3 FURVENT Trial of Firmonertinib in First-Line EGFR Exon 20 Insertion Mutant NSCLC
globenewswire.com
AVBP
Form 8-K
sec.gov
AVBP
ArriVent BioPharma Reports Second Quarter 2026 Financial Results
globenewswire.com
AVBP
Form 8-K
sec.gov
AVBP
Form 8-K
sec.gov
AVBP
Form 8-K
sec.gov
AVBP
ArriVent BioPharma Reports First Quarter 2026 Financial Results
globenewswire.com
AVBP
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
globenewswire.com
AVBP